James Wooldridge SEC EDGAR Filings (CIK 0001710641)

SEC EDGAR filings, ownership reports, and insider transactions for James Wooldridge.

Business address
C/O Checkmate Pharmaceuticals, Inc., 245 Main Street, 2 Nd Floor, Cambridge, MA, 02142
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
James Wooldridge has filed 10 SEC EDGAR filings since 10 Jul 2017

Latest Filings

Recent SEC filings for James Wooldridge including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 31 May 2022 31 May 2022 001-39425
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Apr 2022 04 Mar 2021 001-39425
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 31 Jan 2022 27 Jan 2022 001-39425
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Aug 2021 04 Aug 2021 001-39425
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Aug 2020 06 Aug 2020 001-39425
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 06 Aug 2020 06 Aug 2020 001-39425
4 Open 4 document View SEC filing for 4 FORM 4 01 Mar 2019 28 Feb 2019 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 22 Feb 2018 20 Feb 2018 001-37722
4 Open 4 document View SEC filing for 4 FORM 4 24 Aug 2017 22 Aug 2017 001-37722
3 Open 3 document View SEC filing for 3 FORM 3 10 Jul 2017 10 Jul 2017 001-37722

About this filer

James Wooldridge files with the SEC under CIK 0001710641. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages